meclofenamic acid has been researched along with Ischemic Attack, Transient in 4 studies
Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin, known to inhibit platelet function markedly, seems to have little effect on isolated vascular smooth muscle." | 1.26 | Cerebral vasospasm: effects of prostaglandin synthetase inhibitors in vitro. ( Chapleau, CE; Robertson, JT; White, RP, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| White, RP | 2 |
| Robertson, JT | 2 |
| Chapleau, CE | 1 |
| Bucci, MN | 1 |
| Black, KL | 1 |
| Hoff, JT | 1 |
| Suzuki, S | 1 |
| Iwabuchi, T | 1 |
| Tanaka, T | 1 |
| Kanayama, S | 1 |
| Ottomo, M | 1 |
| Hatanaka, M | 1 |
| Aihara, H | 1 |
4 other studies available for meclofenamic acid and Ischemic Attack, Transient
| Article | Year |
|---|---|
Comparison of piroxicam, meclofenamate, ibuprofen, aspirin, and prostacyclin efficacy in a chronic model of cerebral vasospasm.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Behavior, Animal; Cerebral Angiography; Disease Models, | 1983 |
Cerebral vasospasm: effects of prostaglandin synthetase inhibitors in vitro.
Topics: Animals; Arachidonic Acids; Aspirin; Basilar Artery; Cyclooxygenase Inhibitors; Dogs; Female; In Vit | 1980 |
Arachidonic acid metabolite production following focal cerebral ischemia: time course and effect of meclofenamate.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cerebral Arteries; Constriction; Dinoprostone; Ischemic Attac | 1990 |
Prevention of cerebral vasospasm with OKY-046 an imidazole derivative and a thromboxane synthetase inhibitor. A preliminary co-operative clinical study.
Topics: Acrylates; Adult; Aged; Drug Eruptions; Female; Hemorrhage; Humans; Intracranial Aneurysm; Ischemic | 1985 |